Dobbs Ferry, January 28, 2007 – Smarting from its surprise defeat in the November election to the Democratic ticket, the Dobbs Ferry (Pharmacy) Party struck back with the only weapon left in their quiver – a referendum to move the election date back to March. By way of background, the Dobbs Ferry Party had dominated […]
Investor News: Deadline upcoming in Settlement in the Lawsuit against BioScrip Inc (NASDAQ: BIOS)
A deadline is coming up on July 12, 2016 in the settlement reached in the securities class action lawsuit filed on behalf of investors in NASDAQ: BIOS shares between November 9, 2012 and November 6, 2013. Investors who purchased a significant amount of shares of BioScrip Inc (NASDAQ: BIOS) between November 9, 2012 and November […]
Investor News: Investigation over March 18, 2015 Secondary Offering by Valeant Pharmaceuticals Intl Inc (NYSE:VRX)
An investigation for investors in the March 18, 2015 Secondary Offering at $199.00 per share, was announced concerning over potential securities laws violations. Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) declined from $262.52 per share in August 2015 to as low as $25.98 per share on March 21, 2016. Investors who purchased shares of Valeant […]
Investor News: Deadline upcoming in Settlement in the Lawsuit against CVS Corporation (NYSE: CVS)
A deadline is coming up on March 23, 2016 in the settlement reached in the securities class action lawsuit filed for investors who purchased shares of CVS Corporation (NYSE: CVS) between October 30, 2008 and November 4, 2009. Investors who purchased a significant amount of shares of CVS Corporation (NYSE: CVS) between October 30, 2008 […]
Investor News: Valeant Pharmaceuticals Intl Inc (NYSE:VRX) faces Investigation over potential Wrongdoing
An investigation for investors in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was announced over potential breaches of fiduciary duties by certain directors at Valeant Pharmaceuticals Intl Inc. Investors who purchased shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554. The investigation […]
Long-Term Investor Alert: Investigation over potential Wrongdoing at BioScrip Inc (NASDAQ:BIOS)
The Shareholders Foundation announces that an investigation for investors, who currently hold shares of in shares of BioScrip Inc (NASDAQ:BIOS) long-term, shares was launched concerning potential wrongdoing by certain directors of BioScrip Inc that caused damages to NASDAQ:BIOS stockholders. Investors who purchased shares of BioScrip Inc (NASDAQ:BIOS) have certain options and should contact the Shareholders […]
- 1
- 2
- 3
- 4
- Next Page »